Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III), By Product & Services, By End Use, By Therapeutic Use, By Region, And Segment Forecasts, 2022 - 2030
... new report by Grand View Research, Inc. This growth can be attributed to the increasing volume of clinical trial studies coupled with the growing complexity of conducting these trials. The COVID-19 pandemic has created opportunities ... Read More
-
Global Omics-Based Clinical Trials Market Size study, by Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Indication (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases)) and Regional Forecasts 2022-2028
... CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases)) and Regional Forecasts 2022-2028 Global Omics-Based Clinical Trials Market is valued at approximately USD 24.4 billion in 2021 and is anticipated ... Read More
-
Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing, Supply/Logistics), By Phase (Phase I, II, III, IV), By Region (APAC, North America), And Segment Forecasts, 2022 - 2030
... Clinical Trial Equipment & Ancillary Solutions Market Growth & Trends The global clinical trial equipment & ancillary solutions market is expected to reach USD 5.09 billion by 2030, expanding at a CAGR of 8.1% over ... Read More
-
2022 Global Forecast for Clinical Trial Imaging (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Clinical Trial Supplies (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... there will be more than 182 million diagnosed prevalent cases of dysphagia across 16 pharmaceutical markets. There is no US FDA approved marketed product for the treatment of dysphagia. R&D activity in dysphagia is minimal, ... Read More
-
Pharmaceutical Analytical Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 11,387.35 million by 2027, registering a CAGR of 8.20% from 2022 to 2027. While the sudden outbreak of the COVID-19 pandemic has negatively impacted most business sectors, the pharmaceutical analytical testing market has shown consistent ... Read More
-
Pharmaceutical Contract Manufacturing Organization (CMO) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... expected to reach USD 204.14 billion by 2027, registering a CAGR of 6.64% from 2022 to 2027. As a result of the rising demand for generic medicines and biologics, the capital-intensive nature of the business, ... Read More
-
Life Sciences Analytics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... USD 13,871.66 million by 2027 while registering a CAGR of 7.91% during 2022-2027. The recent outbreak of COVID – 19 has been contributing to the rise in demand for analytics, as there are several clinical ... Read More
-
Anxiety Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... there will be more than 291 million prevalent cases of anxiety across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of anxiety, Viatris is a key player in the disease space. ... Read More
-
Clinical Trials Support Services Market Size, Share & Trends Analysis Report By Service (Clinical Trial Site Management, Patient Recruitment Management), By Phase, By Sponsor, By Region, And Segment Forecasts, 2022 - 2030
... Services Market Growth & Trends The global clinical trials support services market is expected to reach USD 37.1 billion by 2030, registering a CAGR of 7.5% from 2022 to 2030, according to a new report ... Read More
-
Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 36 million prevalent cases of lopecia areata across 16 pharmaceutical markets. No FDA-approved marketed drugs are available for Alopecia areata; however, there are several treatments used off-label to ... Read More
-
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 158,442 diagnosed prevalent cases of pancreatic cancer across 16 pharmaceutical markets. There are five leading marketed drugs for the treatment of pancreatic cancer, AstraZeneca is a key player ... Read More
-
Vaccine Contract Manufacturing Market Report 2022-2032
... useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors Such As Reduced Market Time, Infrastructure Cost Benefits, And Operational Benefits Are Driving ... Read More
-
Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise, Site), By Delivery Mode (Web & Cloud-based, On-premise), By Component, By End User, By Region, And Segment Forecasts, 2022 - 2030
... 2030 Clinical Trials Management System Market Growth & Trends The global clinical trials management system market size is anticipated to reach USD 4.72 billion by 2030, according to a new report by Grand View Research, ... Read More
-
Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application (Drug Optimization & Repurposing, Preclinical Testing), By Therapeutic Area, By Region, And Segment Forecasts, 2022 - 2030
... Discovery Market Growth & Trends The global artificial intelligence in drug discovery market size is expected to reach USD 9.1 billion by 2030, according to a new report by Grand View Research, Inc. It is ... Read More
-
Global Clinical Trials Market 2022-2028
... test medical interventions including drugs, cells and other biological products, surgical procedures, radiological procedures, devices, behavioural treatments and preventive care. Garnering a CAGR of 5.3% from 2022 to 2028, the global clinical trials market is ... Read More
-
Central Lab Market (Product: Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services, Clinical Research & Trial Services, and Others; and End-user: Pharmaceutical Companies, Biotechnology Companies, and Academic & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
... Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 Central Lab Market – Scope of Report TMR’s report on the global central lab market studies the past as well as the ... Read More
-
Global Clinical Trial Kits Market 2022-2028
... or treatments are both safe and effective. The global clinical trial kits market is expected to increase by USD 327 million, at a compound annual growth rate (CAGR) of 7.4% from 2022 to 2028, according ... Read More
-
Contract Research Organization (CRO) Market Size By Service Type (Early Phase Development Services {Discovery Services, Chemistry, Manufacturing & Control (CMC), Pre-clinical Services [Pharmacokinetics/Pharmacodynamics (PK/PD), Toxicology Testing Services]}, Clinical Research Services {Phase I, Phase II, Phase III, Phase IV}, Laboratory Services {Bioanalytical Testing Services, Analytical Testing Services [Physical Characterization, Raw Material Testing, Batch Release Testing, Stability Testing]}, Regulatory Consulting Services), By Therapeutic Area (Oncology, Clinical Pharmacology, Cardiology, Infectious Disease, Neurology, Gastroenterology & Hepatology, Ophthalmology), By End-use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... III, Phase IV}, Laboratory Services {Bioanalytical Testing Services, Analytical Testing Services [Physical Characterization, Raw Material Testing, Batch Release Testing, Stability Testing]}, Regulatory Consulting Services), By Therapeutic Area (Oncology, Clinical Pharmacology, Cardiology, Infectious Disease, Neurology, Gastroenterology ... Read More
-
Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update"" provides an overview of Diastolic Heart Failure Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... Lung Cancer therapeutics. Synopsis In 2022, there will be more than 210,000 diagnosed prevalent cases of SCLC across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of SCLC, AstraZeneca is a ... Read More
-
Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
... food. While any food can cause an adverse reaction, eight types of food allergens account for about 90% of all reactions: eggs, milk, peanuts, tree nuts, fish, shellfish, wheat, and soybeans. Food-induced allergic disorders are ... Read More
-
Leading Clinical Trial Supplies Clinical Phase Markets Databank
... from 2021 to 2029. Phase III segment is expected to be the highest contributor to this market, with $771.8 Million in 2020, and is anticipated to reach $1,486.6 Million by 2029, registering a CAGR of ... Read More
-
Latin America, Middle East & Africa Clinical Trial Supplies Market Databank
... CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a ... Read More
Research Assistance
